The Chairman of the Board, Martin Godbout, is pleased to announce the appointment of Marc LePage as President and CEO of G\u00e9nome Qu\u00e9bec.<\/p>\n
Marc LePage was, most recently, Special Advisor, Climate Change and Energy for the Embassy of Canada in Washington, D.C. from September 2009 to the present. He previously served as Consul General at the Canadian Consulate in San Francisco\/Silicon Valley. Mr. LePage was also one of the pioneers behind the founding of Genome Canada in 2000. During his tenure as Executive Vice-President of Corporate Development, he made a significant contribution to the development of
genomics in Canada. From 1994 to 2000, he worked as Director of Business Development for the Medical Research Council, where he was in charge of building international partnerships with the pharmaceutical industry, venture capital and foundations.<\/p>\n
Mr. LePage\u2019s foreign experience constitutes a remarkable asset for G\u00e9nome Qu\u00e9bec, according to Mr. Godbout. He also notes that his arrival at the helm of the organization takes place in a context conducive to the growth of life sciences, as can be seen by the provincial government\u2019s recent commitments. Mr. Godbout explains: \u201cQu\u00e9bec is currently showing a firm and concerted intention to broaden the influence of research and development in Canada and abroad. The marketplace is very favourable to innovation right now and the genomics sector is one of its major pillars. Given the current environment, Marc LePage was our obvious choice, since he possesses solid expertise in international partnerships.\u201d<\/p>\n
Genomics research is at a pivotal point in its history, both in terms of major discoveries and potential spinoffs in health, forestry and the environment. In that light, Mr. LePage points out: \u201cOne of the main challenges that awaits me as President and CEO of G\u00e9nome Qu\u00e9bec involves identifying innovative solutions and entering into strategic agreements for genomics in order to stimulate Qu\u00e9bec\u2019s scientific and economic competitiveness.\u201d<\/p>\n
In coming weeks, Marc LePage will begin a tour to meet the key partners and stakeholders of the genomics sector.<\/p>\n
\u00a0<\/p>\n
About G\u00e9nome Qu\u00e9bec<\/strong><\/p>\n Since May 2000, G\u00e9nome Qu\u00e9bec has been the driving force behind the development of genomics in Qu\u00e9bec. By supporting over 50 projects and 750 researchers and managing the operations of the McGill University and G\u00e9nome Qu\u00e9bec Innovation Centre, G\u00e9nome Qu\u00e9bec is helping to accelerate the discovery of new applications for genomics in strategic The funds invested by G\u00e9nome Qu\u00e9bec are provided by the Ministry of Economic Development, Innovation and Export Trade of Qu\u00e9bec (MDEIE), the Government of Canada through Genome Canada and private partners.For more information, visit\u00a0www.genomequebec.com<\/a>.<\/p>\n \u00a0<\/p>\n -30-<\/p>\n \u00a0<\/p>\n
areas, such as human health, forestry and the environment.<\/p>\n